Teens with advanced-stage Hodgkin lymphoma survive longer without their disease getting worse when they receive the ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap stocks to buy for the next 3 years. On January 9, Scotiabank ...

Tourmaline went public in 2023 via a reverse merger with the struggling cell therapy developer Talaris. The deal gave Tourmaline funds to develop pacibekitug, an antibody that targets interleukin-6, a ...

If you are wondering whether Bristol-Myers Squibb is priced attractively right now, you are not alone. This article walks ...

Streaming ad spending is expected to surge 13% to $12.3 billion this year as advertisers shift budgets from declining traditional television. Viewers increasingly complain about loud, repetitive, ...

The RELATIVITY-098 trial showed no RFS improvement with nivolumab plus relatlimab versus nivolumab alone in resected stage III-IV melanoma. The trial was terminated as it failed to meet its primary ...

Peacock subscribers will see ads immediately upon opening the streaming app or website next year. It’s a bold new strategy for attracting advertisers—something that’s been increasingly important to ...

At the start of a new short film, a young boy is gifted a present of a stuffed wolf at a family dinner—an animal he’s afraid of. We’re soon transported to a forest, where we witness a wily tale of ...

One is a sector mainstay that has now raised its payout 17 years in a row. The other is a big player in the animal healthcare space. It's not too late to take advantage of either. The healthcare ...